Cargando…

Generalized Concentration Addition Predicts Joint Effects of Aryl Hydrocarbon Receptor Agonists with Partial Agonists and Competitive Antagonists

BACKGROUND: Predicting the expected outcome of a combination exposure is critical to risk assessment. The toxic equivalency factor (TEF) approach used for analyzing joint effects of dioxin-like chemicals is a special case of the method of concentration addition. However, the TEF method assumes that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howard, Gregory J., Schlezinger, Jennifer J., Hahn, Mark E., Webster, Thomas F.
Formato:	Texto
Lenguaje:	English
Publicado:	National Institute of Environmental Health Sciences 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866683/ https://www.ncbi.nlm.nih.gov/pubmed/20435555 http://dx.doi.org/10.1289/ehp.0901312

Ejemplares similares

Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context.
por: Zhang, Shu, et al.
Publicado: (2003)

Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study
por: Jensen, Brenda A, et al.
Publicado: (2003)

Direct Assessment of Cumulative Aryl Hydrocarbon Receptor Agonist Activity in Sera from Experimentally Exposed Mice and Environmentally Exposed Humans
por: Schlezinger, Jennifer J., et al.
Publicado: (2010)

Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS
por: Rothhammer, Veit, et al.
Publicado: (2017)

Detection of aryl hydrocarbon receptor agonists in human samples
por: Rothhammer, Veit, et al.
Publicado: (2018)

The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor
por: Ciolino, H P, et al.
Publicado: (1999)

The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor
por: O'Donnell, Edmond F., et al.
Publicado: (2010)

Discovery of 2-aryl and 2-pyridinylbenzothiazoles endowed with antimicrobial and aryl hydrocarbon receptor agonistic activities
por: Goya-Jorge, Elizabeth, et al.
Publicado: (2020)

Lineage-dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis
por: Harrill, Joshua A, et al.
Publicado: (2015)

Characterization of Natural Aryl Hydrocarbon Receptor Agonists from Cassia Seed and Rosemary
por: Amakura, Yoshiaki, et al.
Publicado: (2014)

Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001)
por: Liu, Lisa, et al.
Publicado: (2023)

Aryl Hydrocarbon Receptor Agonist VAF347 Impedes Retinal Pathogenesis in Diabetic Mice
por: Zapadka, Thomas E., et al.
Publicado: (2021)

Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MS
por: Tsaktanis, Thanos, et al.
Publicado: (2020)

Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells
por: Hanieh, Hamza, et al.
Publicado: (2016)

Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis
por: Abdullah, Alzahrani, et al.
Publicado: (2019)

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors
por: Sparre‐Ulrich, A H, et al.
Publicado: (2015)

Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists
por: Chen, Jiaxuan, et al.
Publicado: (2020)

Muscle agonist–antagonist interactions in an experimental joint model
por: Gorkovenko, Andrei V., et al.
Publicado: (2012)

Gut Microbial Catabolites of Tryptophan Are Ligands and Agonists of the Aryl Hydrocarbon Receptor: A Detailed Characterization
por: Vyhlídalová, Barbora, et al.
Publicado: (2020)

Correction: Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis
Publicado: (2019)

Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
por: Prud'homme, Gérald J., et al.
Publicado: (2010)

Synergistic Embryotoxicity of Polycyclic Aromatic Hydrocarbon Aryl Hydrocarbon Receptor Agonists with Cytochrome P4501A Inhibitors in Fundulus heteroclitus
por: Wassenberg, Deena M., et al.
Publicado: (2004)

A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain
por: Perkins, Arden, et al.
Publicado: (2014)

Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells
por: Veldhoen, Marc, et al.
Publicado: (2009)

The Agonist-antagonist Myoneural Interface
por: Herr, Hugh, et al.
Publicado: (2021)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma
por: Slominski, Andrzej T., et al.
Publicado: (2023)

Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor
por: Narasimhan, Supraja, et al.
Publicado: (2018)

Structural insights into Resveratrol’s antagonist and partial agonist actions on estrogen receptor alpha
por: Chakraborty, Sandipan, et al.
Publicado: (2013)

Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
por: Li, Zoe, et al.
Publicado: (2023)

Transcriptomic assessment of resistance to effects of an aryl hydrocarbon receptor (AHR) agonist in embryos of Atlantic killifish (Fundulus heteroclitus) from a marine Superfund site
por: Oleksiak, Marjorie F, et al.
Publicado: (2011)

Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists
por: Ng, Hui Wen, et al.
Publicado: (2014)

Red Clover Aryl Hydrocarbon Receptor (AhR) and Estrogen Receptor (ER) Agonists Enhance Genotoxic Estrogen Metabolism
por: Dunlap, Tareisha L., et al.
Publicado: (2017)

Efficiently Differentiating Agonists and Competitive Antagonists for Weak Allosteric Protein–Ligand Interactions with Linear Response Theory
por: Davolio, Anthony J., et al.
Publicado: (2023)

Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2021)

Standing task difficulty related increase in agonist-agonist and agonist-antagonist common inputs are driven by corticospinal and subcortical inputs respectively
por: Nandi, Tulika, et al.
Publicado: (2019)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Lupinalbin A as the most potent estrogen receptor α- and aryl hydrocarbon receptor agonist in Eriosema laurentii de Wild. (Leguminosae)
por: Ateba, Sylvin Benjamin, et al.
Publicado: (2014)

Skatole (3-Methylindole) Is a Partial Aryl Hydrocarbon Receptor Agonist and Induces CYP1A1/2 and CYP1B1 Expression in Primary Human Hepatocytes
por: Rasmussen, Martin Krøyer, et al.
Publicado: (2016)

Tetrandrine, an agonist of aryl hydrocarbon receptor, reciprocally modulates the activities of STAT3 and STAT5 to suppress Th17 cell differentiation
por: Yuan, Xusheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hacmq81kf9sm9k1dp3ifajvcue